Cargando…
Doxorubicin-loaded dextran-based nano-carriers for highly efficient inhibition of lymphoma cell growth and synchronous reduction of cardiac toxicity
PURPOSE: Cardiac side effects of doxorubicin (Dox) have limited its clinical application. The aim of this study was to explore new Dox-loaded dextran-based nano-carriers (NCs) in efficiently targeting tumor growth with less cardiac toxicity. METHODS: Inspired by recent reports that polymeric NCs cou...
Autores principales: | Fang, Ying, Wang, Hao, Dou, Hong-Jing, Fan, Xing, Fei, Xiao-Chun, Wang, Lei, Cheng, Shu, Janin, Anne, Wang, Li, Zhao, Wei-Li |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6161723/ https://www.ncbi.nlm.nih.gov/pubmed/30288040 http://dx.doi.org/10.2147/IJN.S161203 |
Ejemplares similares
-
Doxorubicin-loaded redox-responsive micelles based on dextran and indomethacin for resistant breast cancer
por: Zhou, Yunfang, et al.
Publicado: (2017) -
Advanced Nano-Carriers for Anti-Tumor Drug Loading
por: Xiang, Jia, et al.
Publicado: (2021) -
Carriers Based on Zein-Dextran Sulfate Sodium Binary Complex for the Sustained Delivery of Quercetin
por: Wang, Tian-xing, et al.
Publicado: (2020) -
Salmonella-innovative targeting carrier: Loading with doxorubicin for cancer treatment
por: Rabea, Sameh, et al.
Publicado: (2020) -
Dextran-Cholesterol Carrier Encapsulated Efficient Photosensitizer for the Photodynamic Killing of Cancer Cells
por: Wu, Biru, et al.
Publicado: (2023)